Walleye Capital LLC Takes Position in Ingevity Corporation $NGVT

Walleye Capital LLC purchased a new position in shares of Ingevity Corporation (NYSE:NGVTFree Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 19,071 shares of the company’s stock, valued at approximately $1,358,000.

Other hedge funds also recently modified their holdings of the company. Global Retirement Partners LLC bought a new stake in shares of Ingevity in the 4th quarter worth approximately $27,000. Meeder Asset Management Inc. bought a new position in Ingevity during the fourth quarter valued at $33,000. Kestra Advisory Services LLC bought a new position in Ingevity during the fourth quarter valued at $47,000. Geneos Wealth Management Inc. increased its position in Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after buying an additional 387 shares during the last quarter. Finally, Frazier Financial Advisors LLC purchased a new stake in Ingevity in the first quarter worth $71,000. Institutional investors own 91.59% of the company’s stock.

Analyst Upgrades and Downgrades

NGVT has been the topic of several research reports. Wall Street Zen upgraded Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research note on Friday, July 17th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Ingevity currently has a consensus rating of “Hold” and a consensus target price of $80.00.

Read Our Latest Stock Report on NGVT

Ingevity Stock Performance

Shares of NGVT stock opened at $73.64 on Friday. The stock has a market capitalization of $2.56 billion, a P/E ratio of -20.75 and a beta of 1.16. The company has a current ratio of 1.42, a quick ratio of 0.92 and a debt-to-equity ratio of 27.83. The firm’s 50 day moving average is $70.97 and its 200 day moving average is $70.60. Ingevity Corporation has a 12 month low of $39.74 and a 12 month high of $79.29.

Ingevity (NYSE:NGVTGet Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The business had revenue of $258.00 million during the quarter, compared to analyst estimates of $254.73 million. During the same period in the previous year, the business earned $1.01 EPS. Ingevity’s revenue was up 4.1% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, sell-side analysts anticipate that Ingevity Corporation will post 5.05 earnings per share for the current year.

Insider Activity at Ingevity

In other news, SVP Terrance M. Dyer sold 496 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.88% of the stock is owned by insiders.

About Ingevity

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Read More

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVTFree Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.